Potency determinations of acetylcholinesterase inhibitors using Ellman's reaction-based assay in screening: Effect of assay variants.

In primary drug discovery screenings and potency determinations of active acetylcholinesterase (AChE) inhibitors, different variations of the Ellman's reaction-based assay are extensively applied. However, these are prone to produce variable results. Here we studied how assay variants differing in the order of reagent addition and substrate concentrations influence potency measurements of AChE inhibitors. Three model compounds were used: tacrine, physostigmine, and a newly reported inhibitor, 1-[5-[4-[(hexahydro-1H-azepin-1-yl)carbonyl]-1-piperidinyl]-1,3,4-thiadiazol-2-yl]-2-pyrrolidinone. Different patterns of potency changes related to the different inhibition mechanisms of the compounds were detected. Recognizing this, better judgment can be applied when publishing results and selecting optimal screening assays.

[1]  R. Verpoorte,et al.  Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. , 2003, Phytochemical analysis : PCA.

[2]  A. Al‐Jafari.  The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[3]  P. Vuorela,et al.  Linarin, a selective acetylcholinesterase inhibitor from Mentha arvensis. , 2006, Fitoterapia.

[4]  Anabella Villalobos,et al.  Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. , 2004, European journal of pharmacology.

[5]  R. Marum,et al.  Current and future therapy in Alzheimer's disease. , 2008 .

[6]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[7]  Wei-Ke Lv,et al.  Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods. , 2010, European journal of medicinal chemistry.

[8]  Atta-ur-Rahman,et al.  Acetyl and butyrylcholinesterase-inhibiting triterpenoid alkaloids from Buxus papillosa. , 2001, Phytochemistry.

[9]  Richard B. Silverman,et al.  The Organic Chemistry of Drug Design and Drug Action , 1992 .

[10]  A. Jäger,et al.  Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. , 2007, Journal of ethnopharmacology.

[11]  S. Sung,et al.  Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships. , 2001, Journal of natural products.

[12]  M. Gütschow,et al.  Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile , 2009, The FEBS journal.

[13]  J. Stojan,et al.  Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine. , 1997, Biochimica et biophysica acta.

[14]  Wei Qiao,et al.  Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase. , 2009, European journal of medicinal chemistry.

[15]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[16]  P. Wakeley,et al.  Synthesis , 2013, The Role of Animals in Emerging Viral Diseases.

[17]  H. Ogura,et al.  Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. , 2000, Methods and findings in experimental and clinical pharmacology.

[18]  T. Sato,et al.  Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020). , 1995, Biological & pharmaceutical bulletin.

[19]  Ricardo Macarrón,et al.  Design and Implementation of High Throughput Screening Assays , 2011, Molecular biotechnology.

[20]  Miniaturization and validation of the Ellman's reaction based acetylcholinesterase inhibitory assay into 384-well plate format and screening of a chemical library. , 2010, Combinatorial chemistry & high throughput screening.

[21]  B. Yun,et al.  Highly oxygenated and unsaturated metabolites providing a diversity of hispidin class antioxidants in the medicinal mushrooms Inonotus and Phellinus. , 2007, Bioorganic & medicinal chemistry.

[22]  R. V. van Marum,et al.  Current and future therapy in Alzheimer’s disease , 2008, Fundamental & clinical pharmacology.

[23]  J. van der Greef,et al.  High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products. , 2000, Journal of chromatography. A.

[24]  H. Soininen,et al.  Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies. , 2009, Current Alzheimer research.